Vimarsana
Biggest News Aggregation in the World

Page 16 - Euronext News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Euronext. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Euronext Today - Breaking & Trending Today

VEON Progresses with Asset-Light Strategy, Reaches Agreement to Sell Stake in TNS+ in Kazakhstan - VEON (NASDAQ:VEON) - Vimarsana News

VEON Progresses with Asset-Light Strategy, Reaches Agreement to Sell Stake in TNS+ in Kazakhstan - VEON (NASDAQ:VEON)

Amsterdam and Astana, 28 May 2024: VEON Ltd. (NASDAQ:VEON, Euronext Amsterdam: VEON)), a global digital operator that provides converged connectivity and online services, announces that it has signed an agreement

Flow Traders Ltd: Repurchase of Shares - Vimarsana News

Flow Traders Ltd: Repurchase of Shares

Repurchase of Shares Amsterdam, the Netherlands - Flow Traders Ltd. (Euronext: FLOW) has repurchased 44,443 of its own shares in the period from 20 May 2024 up to and including 22 May 2024 at an average

Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP) Position Decreased by Edmond DE Rothschild Holding S.A. - Vimarsana News

Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP) Position Decreased by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. lowered its stake in Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP – Free Report) by 47.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 78,469 shares of the company’s stock after selling 69,734 shares during the period. Edmond DE […]

Elix Rental Housing SOCIMI II S A : ERHS II - Ordinary & Extraordinary General Meeting of Shareholders (Jun.24) - Vimarsana News

Elix Rental Housing SOCIMI II S A : ERHS II - Ordinary & Extraordinary General Meeting of Shareholders (Jun.24)

ERHS II - Ordinary & Extraordinary General Meeting of Shareholders 28 May 2024 21:03 CEST Subscribe ...

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call - Vimarsana News

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call

New data from the completed dose escalation part and ongoing expansion part of Study 1100, an ongoing US Phase 1 study evaluating NBTXR3 followed by anti-PD-1 in patients with recurrent or metastatic...